What is the recommended treatment and medication for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cellulitis: Symptoms and Medication

Clinical Presentation

Cellulitis presents as a diffuse, superficial, spreading skin infection characterized by erythema, warmth, tenderness, and swelling without pus collection. 1, 2

  • The infection involves the deep dermis and subcutaneous tissue 2
  • Patients typically experience severe pain and systemic symptoms 3
  • The affected area shows expanding erythema with associated edema 2, 4
  • Purulent drainage or abscess formation is NOT typical of cellulitis - if present, this represents a different type of skin infection requiring different management 1

Recommended Antibiotic Treatment

First-Line Therapy for Uncomplicated Cellulitis

For nonpurulent cellulitis, use antibiotics active against streptococci, as β-hemolytic streptococci are the predominant pathogens. 1

Recommended oral antibiotics include: 1, 5

  • Cephalexin 500 mg four times daily 5
  • Penicillin 1, 5
  • Amoxicillin 5
  • Dicloxacillin 5
  • Clindamycin 1, 5

Duration of Treatment

A 5- to 6-day course of antibiotics is recommended for patients with uncomplicated cellulitis who can self-monitor and have close follow-up. 1

  • Treatment should be extended only if the infection has not improved after 5 days 1, 5
  • The NICE guideline supports 5 to 7 days as adequate duration 1
  • Multiple RCTs demonstrate that shorter courses (5-6 days) achieve similar clinical outcomes to longer courses (10-14 days) 1

When to Add MRSA Coverage

Do NOT routinely add MRSA coverage for typical nonpurulent cellulitis. 5, 6, 7

Add MRSA-active antibiotics (such as trimethoprim-sulfamethoxazole or doxycycline) ONLY in these specific situations: 1, 5

  • Cellulitis associated with penetrating trauma 1, 5
  • Evidence of MRSA infection elsewhere on the body 1, 5
  • Nasal colonization with MRSA 1
  • Injection drug use 1, 5
  • Systemic inflammatory response syndrome (SIRS) 1, 5
  • Purulent drainage present 5

The evidence strongly supports this approach: Two large randomized controlled trials demonstrated that adding trimethoprim-sulfamethoxazole to cephalexin provided no benefit over cephalexin alone for uncomplicated cellulitis. 6, 7 In the most recent trial of 496 patients, clinical cure occurred in 83.5% with combination therapy versus 85.5% with cephalexin alone (no significant difference). 7

Adjunctive Measures

Elevate the affected area to promote drainage of edema and inflammatory substances. 5

Consider adding prednisone 40 mg daily for 7 days in non-diabetic adults to reduce inflammation and hasten resolution. 5

When to Hospitalize

Most patients can be treated as outpatients. 5

Consider hospitalization if any of the following are present: 5

  • Systemic inflammatory response syndrome (SIRS) 5
  • Altered mental status 5
  • Hemodynamic instability 5
  • Concern for deeper or necrotizing infection 5
  • Poor adherence to therapy 5
  • Severe immunocompromise 5

Prevention of Recurrence

Identify and treat predisposing conditions at the initial visit: 5, 4

  • Tinea pedis (athlete's foot) 4
  • Chronic edema 4
  • Cutaneous lesions 4

For patients with frequent recurrences (3-4 episodes per year), consider prophylactic antibiotics such as oral penicillin, erythromycin, or intramuscular benzathine penicillin. 5

Critical Pitfalls to Avoid

Do not extend antibiotic treatment beyond 5-6 days if clinical improvement has occurred - this increases antibiotic resistance without improving outcomes. 1, 5

Do not automatically add MRSA coverage for typical nonpurulent cellulitis - research demonstrates no benefit and increases unnecessary antibiotic exposure. 5, 6, 7

Do not obtain blood cultures or tissue aspirates routinely - these are not needed for typical cases of cellulitis. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Research

Interventions for cellulitis and erysipelas.

The Cochrane database of systematic reviews, 2010

Research

Cellulitis.

Infectious disease clinics of North America, 2021

Guideline

Treatment of Finger Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.